Community Hospital Anderson Clinical Research Center

At Community Hospital Anderson Clinical Research Center (CCRC), we work daily on helping doctors and patients find the newest and most cutting edge solutions to their medical issues. Our studies are always changing and this is a place to keep you updated on what is going on at CCRC including external medical advances along with information about our current and upcoming studies. Thanks for checking us out and feel free to contact us anytime!!

Pages

  • Home
  • What Is A Clinical Trial?
  • Stay Connected with CCRC
  • About Us

Wednesday, April 13, 2011

Novartis Gilenya

Novartis therapy Gilenya reduced the risk of MS disability progression regardless of treatment history of disease severity, new analysis shows
Posted by Community Clinical Research Center at 10:14 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Followers

Blog Archive

  • ▼  2011 (12)
    • ►  December (4)
    • ►  November (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (4)
    • ▼  April (1)
      • Novartis Gilenya
  • ►  2010 (17)
    • ►  December (1)
    • ►  November (1)
    • ►  September (2)
    • ►  August (4)
    • ►  July (4)
    • ►  June (4)
    • ►  May (1)

Search This Blog

Simple theme. Powered by Blogger.